Business · 31/03/2023

FDA Releases Draft Guidance on Research Involving Children as Subjects

The Food and Drug Administration (FDA) has released a draft guidance document to assist institutional review boards, institutions, investigators, and sponsors in understanding the process for reviewing research involving children as subjects that cannot be approved by an Institutional Review Board (IRB) and has been referred to the FDA and the Office for Human Research Protections (OHRP).